Sustained Release Formulation Excipients in Modern Pharmaceuticals
Sustained release excipients are becoming central to modern pharmaceutical innovation as drug manufacturers focus on improving patient compliance, therapeutic efficiency, and product differentiation. These excipients enable drugs to be released gradually over an extended period, reducing dosing frequency and maintaining consistent drug levels in the bloodstream. As healthcare systems prioritize convenience and better treatment outcomes, sustained release technologies are gaining strong commercial relevance. The rise in chronic diseases, aging populations, and long-term therapies is accelerating the demand for advanced drug delivery systems. Pharmaceutical companies are reformulating existing drugs using sustained release excipients to extend product life cycles, enhance performance, and meet evolving regulatory standards. This trend is particularly significant as patent expirations push manufacturers to innovate through formulation improvements rather than new molecular entities....